Skip to main content

Table 2 Patient descriptions

From: Selection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study

IDAgeMMSE or HDS-R scoreOnset (years prior to the study)Functional autonomyHow did the patient learn about BT and make a decision?
A45–49MMSE = 245Could go out with a cane and a lower extremity orthosis.BT was introduced by the primary physician.
Patient selected BT injection to enhance gait stability and improve upper limb activity.
B55–59MMSE = 2910Could go out with a cane and a lower extremity orthosis.BT was introduced by the primary physician.
Patient selected BT injection to enhance gait stability and improve upper limb activity.
C60–64HDS-R = 264Could go out.BT recommended for a tingling sensation in the foot.
Patient did not select BT injection owing to the possibility of convulsions.
D60–64MMSE = 288Could go out with a cane and a lower extremity orthosis under supervision.Patient was looking for better treatment options and obtained information about BT.
Selected BT injection to enhance gait stability and improve upper limb activity.
E60–64HDS-R = 269Could go out with a cane and a lower extremity orthosis.Patient heard about BT from patients who had received BT and healthcare professionals. Selected BT injection to enhance gait stability.
F70–74MMSE = 266Could go out with a cane and a lower extremity orthosis under supervision.BT recommended by healthcare professionals and family members.
Selected BT injection to enhance gait stability and improve upper limb activity.
  1. BT Botulinum toxin, MMSE Mini-Mental State Examination, HDS-R Revised Hasegawa’s Dementia Scale